The shooting at the Wildberries office led to the death of one person
18 September 15:09
In Russia, there is an acute shortage of such a medical product as antiresus immunoglobulin
14:39; 08 August 2024 year
© Freepik Company
In Russia in 2024, there is an acute shortage of such a drug as antiresus immunoglobulin. This is, in particular, reported by the publication «RBC ». This drug is necessary for pregnant women with a negative Rh factor.
It is known that in the first half of this year, about 48 thousand packages of the drug entered the Russian market, which is 71% less than in the same period of 2023. The main reason is the reduction of supplies from abroad. It is not known why the supplies stopped.Currently, the market for antiresus immunoglobulin in Russia is being formed by foreign companies. The largest market share (49.2%) was previously occupied by a drug from the Italian Kedrion Biopharm called Immunoro Kedrion. The drug «Kamrow» from the Israeli company Kamada at the same time occupied 32.5% of the Russian market, for the drug «Rezogam N» from an international company CSL Behring accounted for 14%.
